Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration
- 1 April 2016
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 619, 142-148
Abstract
No abstract availableKeywords
Funding Information
- Major Program of the National Natural Science Foundation of China (81330023)
- National Natural Science Foundation of China (81302709)
- Shanghai Committee of Science and Technology (14DZ2260300, 14DJ1400200)
- Shanghai municipal foundation for young scientists (2012Y343)
- XinHua Hospital Foundation (13YJ19)
This publication has 24 references indexed in Scilit:
- Dexamethasone uptake in the murine organ of Corti with transtympanic versus systemic administrationJournal of Otolaryngology - Head & Neck Surgery, 2013
- Protecting the auditory system with glucocorticoidsHearing Research, 2011
- Late Onset Hearing Loss: A Significant Complication of Cancer Survivors Treated With Cisplatin Containing Chemotherapy RegimensJournal of Pediatric Hematology/Oncology, 2010
- Cisplatin-Induced OtotoxicityOtology & Neurotology, 2008
- The Histone Deacetylase Inhibitor Sodium Butyrate Protects Against Cisplatin‐Induced Hearing Loss in Guinea PigsThe Laryngoscope, 2006
- Ototoxicity: therapeutic opportunitiesDrug Discovery Today, 2005
- Intratympanic Steroid Injection for Treatment of Idiopathic Sudden Hearing LossOtolaryngology–Head and Neck Surgery, 2005
- Predicting cisplatin ototoxicity in children: the influence of age and the cumulative doseEuropean Journal of Cancer, 2004
- Glucocorticoid receptor expression in the postnatal rat cochleaHearing Research, 1995
- The Efficacy of Steroids in the Treatment of Idiopathic Sudden Hearing Loss: A Double-blind Clinical StudyJAMA Otolaryngology–Head & Neck Surgery, 1980